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ABSTRACT
OBJECTIVE: To determine whether scores in an adapted version of the self-assessment 
Pubertal Development Scale into Portuguese match those from the gold standard in pubertal 
development (Tanner scale). 
METHODS: This was a cross-sectional study with a convenience sample of 133 children and 
adolescents aged nine to 17 years (59 males; mean age of 13 years and six months, with standard 
deviation = 25 months). Youngsters completed the Pubertal Development Scale and were then 
examined by specialists in adolescent medicine. 
RESULTS: Exact absolute agreement of pubertal stages were modest, but significant associations 
between measures (correlation; intra-class correlation coefficients of consistency) showed 
that the Pubertal Development Scale adequately measures changes that map onto pubertal 
development determined by physical examination, on par with international publications. 
Furthermore, scores obtained from each Pubertal Development Scale question reflected 
adequate gonadal and adrenal events assessed by clinical ratings, mostly with medium/high 
effect sizes. Latent factors obtained from scores on all Pubertal Development Scale questions 
had excellent fit indices in Confirmatory Factor Analyses and correlated with Tanner staging. 
CONCLUSIONS: We conclude that self-assessment of body changes by youngsters using the 
Portuguese version of the Pubertal Development Scale is useful when estimates of pubertal 
progression are sufficient, and exact agreement with clinical staging is not necessary. The 
Pubertal Development Scale is, therefore, a reliable instrument for use in large-scale studies 
in Brazil that aim at investigating adolescent health related to pubertal developmental. The 
translated version and scoring systems are provided.
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INTRODUCTION
Puberty involves a set of neuroendocrine changes that occur during the transition from 
childhood to sexual maturity1,2. Age is not a good predictor of pubertal development because 
the timing of puberty and individual’s puberty relative to that of others of the same age and 
sex and also the progression speed (tempo) to full sexual maturity vary widely and depend 
on genetic, ethnic, nutritional, and psychosocial factors2–4. Because of this variability, 
adequate assessment of pubertal onset and progression is crucial to detect disorders that 
may affect this process2,5. This is also important in studies that aim to better understand 
adolescence and how it relates to a variety of biopsychosocial factors.
The gold standard in pubertal development rating is the Tanner scale (e.g., Tanner and 
Marshal)6,7, also known as Tanner stages and Tanner rating. This method classifies puberty 
into five progressive stages6,7, considering changes that occur independently2 in: a) size and 
shape of the breasts in girls and genitals in boys, which reflect mainly activation of the 
hypothalamic-pituitary-gonadal axis1; and b) the distribution and characteristics of pubic 
hair in both sexes, which reflect increased output of steroids due to the expansion of the 
adrenal zona reticularis8. 
The Tanner scale requires physical examinations conducted by extensively trained clinicians2. 
Ratings using this method are therefore not always possible due to the high costs of hiring 
these professionals and providing adequate settings for examinations, especially in studies 
with large samples2. To circumvent these limitations, an alternative method for pubertal 
staging was proposed: the Pubertal Development Scale (PDS)9,10. The PDS is a self-assessment 
scale composed of five questions that enquire about gonadal, adrenal and growth factors that 
alter the body during puberty1,3,8,11–14, which is therefore multidimensional in terms of assessing 
neuroendocrine changes in this phase of life. This scale does not have illustrations of pubertal 
stages; it does not mention genitalia, nor involve been seen naked or palpated. Thus, this scale 
is extensively used in the literature because it is less embarrassing for youngster, is cheaper 
and easier to administer than Tanner ratings, and can be applied in a variety of settings (e.g., 
in schools or in mail or online studies) and populations2. Furthermore, PDS scores capture 
genetic and nonshared environmental factors that influence pubertal development15 and 
correlate both with bone mineral density/mineral content16 and with gonadal and adrenal 
hormone concentrations17,18, in some cases even more so than clinical staging17.
Petersen et al.9 and Carskadon and Acebo10 claimed that the PDS has adequate validity, but 
only the latter compared PDS scores to Tanner staging, and did so only with a small group of 
participants. In fact, very few studies have compared PDS scores to clinical ratings 2, which 
is surprising considering the popularity of this self-assessment scale. Internal consistency 
reliability (Cronbach’s alpha) of the PDS range from questionable to acceptable9,10,19.
The aims of the study proposed here were to: a) adapt the PDS for use in Brazil; and b) 
determine the extent to which self-assessment with this translated scale corresponded 
to clinical Tanner staging rated by physicians trained in adolescent medicine (validity 
criterion) using a variety of statistical approaches, including Structural Equation Modeling.
METHODS
Participants
Consecutive Portuguese speaking patients aged nine to 17 years who attended medical 
centers that treat adolescents at the Hospital São Paulo, in Brazil, for four months. The only 
exclusion criterion was reporting difficulties in reading and writing. Patients with health 
conditions influencing pubertal development were not excluded because our objective was 
to study the relationship between clinical Tanner staging and self-assessment of pubertal 
development, rather than to characterize puberty onset, timing, or tempo.
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Procedure
Firstly, the scale was translated into Portuguese (see Adaptation process below).  We then 
tested the adequacy of the adapted version in a cross-sectional study approved by the Ethics 
Committee at the institution in which the study took place (#2.001.042). Consecutive patients 
were approached in waiting rooms before their consultations and received explanations 
about the study. Those who agreed to take part in the study provided written informed 
consent or assent. Guardians filled out a demographic questionnaire that also enquired 
about age of menarche if applicable. Youngsters were asked to complete the PDS and other 
behavioral questionnaires that will not be addressed here. Participants then underwent 
their consultations, during which physicians rated their pubertal stage on the Tanner scale. 
Physicians were blind to patients’ self-ratings of pubertal development.
Adaptation process of the PDS into Portuguese (Box)
The original PDS proposed by Carskadon and Acebo10 was translated into Portuguese by 
a native speaker of both English and Portuguese, and back-translated by a person with 
similar language skills. Both translated and back-translated versions were then analyzed 
by three specialists in adolescent medicine and three researchers specialized in cognition. 
They determined the adequacy of the translated version and proposed slight alterations to 
improve the understanding of the scale: 1) The Likert rating “seems complete” was found to be 
unclear, so details pertaining each question were added to indicate maximum development 
had been reached (e.g., for growth spurt, the following was added: “I am not growing so 
fast any longer”); 2) A term in Portuguese for growth spurt (estirão de crescimento) exists, 
so it was added in brackets after “rapid growth in height”; 3) For the word “breast” we also 
included various alternative terms that are used in Brazil (peitos, seios, mamas). The scale in 
Portuguese, the instructions for completion and the scoring system can be found in Box 1. 
Measures
• Clinical Tanner staging6,7 by physical examination: participants’ pubertal staging 
(stage 1 to 5) was rated by development of genitals in boys, breasts in girls, and pubic 
hair in both sexes. Palpation of testes and breasts was performed in early genital 
stages2. When in doubt between two adjacent stages, clinicians were instructed to 
rate patients with the mean stage20. In the facilities where male and female patients 
were examined, ratings were conducted by specialists in adolescent health and one 
resident at the end of her training in the field. Until the middle of the study, all ratings 
were checked by a single expert. As no inconsistencies were found, we did not assess 
inter-rater variability.
• The participants’ self-reported development using the translated and adapted version 
of the Pubertal Development Scale (PDS)10: the PDS is a self-assessment instrument (see 
Box) composed of five questions pertaining to growth spurt, body hair, and changes 
in skin for both sexes, rated on 5-point scales: “not yet started” (scored as one point), 
“barely started” (two points)”, “definitely started” (three points)”, “seems complete” (four 
points), “I don’t know” (treated as missing values). On a similar scale, males also rate their 
development regarding changes in voice and facial hair growth, while females rate breast 
growth. Females also state whether they have begun to menstruate (scored 1 for “no” and 
4 for “yes”). Note that many studies cite publications other than Carskadon and Acebo10 
as the origin of the scale and scoring system, but these are unpublished manuscripts 
– except that the study by Petersen et al.9 was published, but their research does not 
include the scale, which can be found in Carskadon and Acebo’s10 article. We used three 
scoring systems10,19 (Box): a) PDS1 (the mean score of all five questions); b) PDS2 (sum 
of scores obtained from three sex-specific questions: voice changes and body and facial 
hair growth in males; menarche, body hair and breast growth in females); and c) Puberty 
Category Score (PCS)19: scores from the same questions used to calculate PDS2 converted 
into stages akin to Tanner stages. However, in the latter case PCS scoring for girls was 
4Brazilian Pubertal Development Scale version Pompéia S et al.
https://dx.doi.org/10.11606/s1518-8787.2019053000915
based on Chan et al.19 and differs from the one described in Carskadon and Acebo10 for 
stage 1 (3 points = stage 1), because in this publication10 stage 1 is undistinguishable 
from stage 2 (3 points with no menarche = stage 2). 
Statistical Analysis
Correspondence between clinical pubertal ratings (each of the Tanner stages for breasts, 
male genitalia, male and female pubic hair) and self-assessment (three types of PDS scores), 
Box. The Pubertal Development Scale (PDS) in the translated Portuguese versions: the instructions for completion (A), the Portuguese scale 
(B) and information needed for scoring (C and D).
A. Instructions for completion (in Portuguese)
“As próximas 5 perguntas são sobre as mudanças que podem estar acontecendo com o seu corpo. Essas mudanças normalmente acontecem de forma 
diferente em cada pessoa e idade. Por favor faça um ‘x’ na alternativa que melhor reflete as mudanças que você está percebendo no seu corpo. Se não 
entender uma pergunta ou não souber a resposta, marque um x em ‘não sei’ ou pergunte se houver alguém aplicando a escala”
B. The Pubertal Development Scale (in Portuguese)
Pergunta
Ainda não 
começou
Parece que 
começou
Começou 
com certeza
Parece completo Não sei
For males (Para garotos)
Você diria que seu crescimento rápido em altura (estirão de 
crescimento)
“Não estou 
crescendo mais tão 
rápido”
Você diria que o crescimento dos pelos no seu corpo (como 
embaixo dos braços, sem considerar cabelos na cabeça)
“Parou de 
aumentar”
Você notou mudanças na pele, especialmente espinhas?
“Não está mais 
aumentando”
Você notou engrossamento da voz?
“Não está mais 
engrossando”
Começou a crescer pelos no seu rosto?
“Não está mais 
aumentando”
For females (Para garotas)
Você diria que seu crescimento rápido em altura (estirão de 
crescimento)
“Não estou 
crescendo mais tão 
rápido”
Você diria que o crescimento dos pelos no seu corpo (pelos como 
embaixo dos braços, sem considerar cabelos na cabeça)
“Parou de 
aumentar”
Você notou mudanças na pele, especialmente espinhas?
“Não está mais 
aumentando”
Você notou que seus peitos (seios ou mamas) começaram a 
crescer?
“Não estão mais 
crescendo”
Você já menstruou?
Não ( ) Sim ( ) → Que idade tinha quando menstruou pela 1ª vez?___ Lembra 
mês? ___ Ano?____ 
C. Scoring10,19
For all questions except menarchal status (“já menstruou”): “ainda não começou” = 1 point; “parece que começou” = 2 points; “começou com certeza” 
= 3 points; “parece completo” = 4 points; “não sei” = 0 (missing values). For menarche: “no” = 1 point; “yes” = 4 points. We suggest that one “I don’t 
know” or one missing answer be substituted for the mean points on the other 4 items. 
D. Computation of Pubertal Category Score (PCS) based on Carskadon and Acebo10 except for pre-pubertal scores for girls19
Correspondence to Tanner staging
Males
(add points relative to voice 
changes, facial and body hair 
growth as indicated in C-scoring)
Females
(add points relative to body hair and breast 
growth and consider menarche as indicated 
in C-scoring) 
1 (pre-pubertal) 3 points 2 points (with no menarche)
2 (early-pubertal)
4–5 points (with no 3-point 
answers)
3 points (with no menarche)
3 (mid-pubertal)
6–8 points (with no 4-point 
answers)
4–8 points (with no menarche)
4 (late-pubertal) 9–11 points 1–7 points (with menarche)
5 (post-pubertal) 12 points 8 points (with menarche)
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separately for each sex, were analyzed with: a) Spearman’s rank rho correlations; b) Kendall’s 
tau correlation coefficients, which measures the strength of cross tabulations; c) intra-class 
correlations coefficients (ICC), with 95% confidence intervals, using SPSS software version 
23 and considering independent evaluators, mixed two-way models21 – consistency ICC 
were calculated when Tanner ratings were compared to continuous scores (PDS1 and PDS2), 
while absolute agreement ICC was only obtained when Tanner ratings were compared to 
PCS, since only in this case measures are in the same ordinal scale; and d) weighted Kappa 
values (WK)22 with 95% confidence interval (95%CI)22, comparing only the PCS with Tanner 
staging (expressed in the same scale), using the online tool vassarstats.net. 
The ICC values below 0.50 are considered of low reliability, those between 0.50–0.75 are 
regarded as of moderate reliability, those between 0.75–0.90 are of good reliability, and 
those between 0.90–1.00 are considered excellent21. The WK is an agreement statistic for 
ordinal categories and the proportion of weighted agreement is corrected for chance. 
It involves giving high weights to agreement and responses that differ by one category, 
lower weights if they differ by two and three categories, while no weight is given if they 
differ by more categories. The benchmarks for WK values are: 0.00–0.20 = slight agreement; 
0.21–0.40 = fair agreement; 0.41–0.60 = moderate agreement; 0.61–0.80 = substantial 
agreement; > 0.8 = almost or perfect agreement.
We also ran general linear models (GLM) separately for each sex to determine the proportion 
of variance explained (multiple R2) in the three PDS scores (dependent continuous variables) 
by clinical staging (regarded as a continuous predictor) on the three types of PDS scores in 
different models. Other GLM were also used to determine the extent to which the answers to 
each PDS question (used as factors with each question as a level, each of which with scores 
ranging from one to four) were associated with pubic hair and breasts or genital Tanner 
staging depending on the sex of the participant (continuous predictor) in different models, 
separately for males and females. R2 were used to determine effect sizes: values between 
0.13 and 0.25 are considered medium, and those over 0.26, large23. 
Structural equation modeling was used to determine the adequacy of a latent factor 
obtained from raw scores of all the PDS questions. To do so, we carried out confirmatory 
factor analyses (CFA) on scores of the scale using Mplus version 8.024. The aims of these 
analyses were to: 1) test PDS measurement model fit; 2) evaluate the magnitude of correlation 
between each PDS item and an underlying pubertal development factor. To evaluate the 
goodness of fit of the statistical model we considered25: chi-square, confirmatory fit index 
(CFI), Tucker-Lewis index (TLI), Root Mean Square Error Approximation (RMSEA), and 
Standardized Root Mean Square Residual (SRMR). The following cutoff criteria were used 
to determine a well-fitted model25: a) non statistically significant chi-square (p > 0.05); 
b) RMSEA near or less than 0.06 and a non-significant close fit (Cfit - p > 0.05), a statistical 
test of closeness of model fit using RMSEA; and c) CFI and TLI near or greater than 0.95 
and SRMR less than 0.08.
The PDS internal consistency has been assessed mainly using Cronbach’s alpha in the 
literature, with values varying from questionable to substantial10,11,19. This is so in the 
original version in English9,10 and the PDS versions translated into other languages (see 
Discussion). However, this classical index of internal consistency has many shortcomings25. 
Assumptions must be met before estimating alpha, which is only a good estimate of reliability 
for congeneric measures if: a) measures are true score equivalent and errors of measurement 
are uncorrelated; or b) errors are uncorrelated and the components load uniformly highly 
on the common latent dimensions25. 
These assumptions were never considered when calculating alphas using PDS scores 
in prior investigations. Consequently, the previous reported alphas might be under- 
or over-estimated, so evidence regarding PDS internal consistency are still lacking. 
To overcome the disadvantages of Cronbach’s alpha, scale reliability for male and female 
models was estimated via factor loadings of CFA26–28 in models in which measurement 
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errors are uncorrelated (in the case of the model with data from males), and based on 
Raykov27 for the model with female data (due to the inclusion of a correlation between a 
pair of residual variances; see the Results section). Lastly, we used Pearson correlation to 
evaluate the degree of association between the pubertal latent variable with the two clinical 
assessments regarding body hair growth and breast or male genitals.
RESULTS
Of the 187 youngsters approached in the waiting rooms, 148 (84 females) accepted to take 
part in the study. Here we describe results on the nine to 17 year-olds from whom both 
Tanner staging and PDS were available: 133 individuals (mean age 13 years and six months; 
SD = 25 months) of whom 59 were males (aged 13 years and eight months; SD = 24 months) 
and 74, females (aged 13 years and five months; SD = 27 months). We found no discrepancies 
between reports of guardians’ and participants’ menarche status and age of menarche.
Intermediate ratings between two stages were used by clinicians for only 4.5% of the ratings. 
For the absolute agreement analyses (ICC and WK), these mean ratings were rounded down 
because the next stage had not yet been reached. Male participants in each of the Tanner 
Table 2. Intra-class correlation coefficients (ICC) and weighted Kappa values with 95% confidence 
intervals (95%CI) comparing pubertal staging using Tanner ratings by physical examination and scores 
on the self-assessed pubertal development using the Pubertal Development Scale (PDS), per sex.
Type of clinical 
Tanner staging
PDS score 
types
Comparison 
statistic
Males (n = 59) Females (n = 74)
Pubic hair PDS1 ICC (consistency) 0.70 (95%CI 0.50–0.82) 0.77 (95%CI 0.64–0.85)
PDS2 ICC (consistency) 0.84 (95%CI 0.74–0.90) 0.78 (95%CI 0.65–0.86)
PCS ICC (agreement) 0.66 (95%CI 0.28–0.82) 0.69 (95%CI 0.31–0.84)
Weighted Kappa 0.32 (95%CI 0.21–0.43) 0.25 (95%CI 0.11–0.39)
Male genitals/ PDS1 ICC (consistency) 0.73 (95%CI 0.54–0.83) 0.83 (95%CI 0.73–0.90)
Female breasts PDS2 ICC (consistency) 0.82 (95%CI 0.70–0.90) 0.81 (95%CI 0.70–0.89)
PCS ICC (agreement) 0.68 (95%CI 0.30–0.84) 0.80 (95%CI 0.44–0.90)
Weighted Kappa 0.30 (95%CI 0.20–0.40) 0.42 (95%CI 0.28–0.56)
PDS1 = mean score of answers to all 5 PDS questions; PDS2 = sum of score of answers to three PDS questions; 
PCS (Pubertal Category Score) = pubertal staging equivalent to the Tanner scale obtained from the PDS2 scoring 
system (see Box for details). Absolute agreement was only tested when comparing ICC and Weighted Kappa of 
Tanner ratings and PCS as only these are rated on a similar scale.
ICC rules of thumb: < 0.50 = low reliability; 0.50–0.75 = moderate reliability; 0.75–0.90 = good 
reliability; 0.90–1.00 = excellent reliability; Weighted Kappa rules of thumb: 0.00–0.20= slight agreement; 
0.21–0.40 = fair agreement; 0.41–0.60 = moderate agreement; 0.61–0.80 = substantial agreement; 
> 0.8 = almost perfect agreement.
Table 1. Spearman and Kendall tau significant (p < 0.0001) correlations between pubertal staging using 
Tanner ratings by physical examination and scores on the self-assessed pubertal development using the 
Pubertal Development Scale (PDS), per sex.
Statistics PDS score
Males (n = 59) Females (n = 74)
Genitals Pubic hair Breasts Pubic hair
Spearman r PDS1 0.77 0.78 0.74 0.65
PDS2 0.75 0.72 0.52 0.41
PCS 0.72 0.67 0.74 0.62
Kendall tau PDS1 0.63 0.64 0.64 0.56
PDS2 0.60 0.60 0.46 0.37
PCS 0.61 0.58 0.70 0.58
PDS1 = mean score of answers to all five PDS questions; PDS2 = sum of score of answers to three PDS questions; 
PCS (Pubertal Category Score) = pubertal staging equivalent to the Tanner scale obtained from the PDS2 scoring 
system (see Box for details).
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genital stages were: eight (stage 1); nine (stage 2); 11 (stage 3); nine (stage 4); 22 (stage 5). 
For females breast stages: two (stage 1); five (stage 2); six (stage 3); 21 (stage 4); 40 (stage 5). 
Correlations between the clinical and PDS scores are in Table 1. Consistency between 
physical ratings and PDS scores (ICC) was mostly moderate to good, while ICC absolute 
agreement and WK results for the PCS were modest (Table 2). Findings obtained from 
Table 3. Results of general linear models per sex in which Tanner staging by physical examination were 
the continuous predictors, and Pubertal Development Scale (PDS) scores were entered as dependent 
continuous variables (either alone or as a factor with answers to individual questions as levels of a 
PDS factor).
Variable PDS metrics Tanner staging R2 Fa  p
Males
Score
PDS1 Pubic hair 0.64 99.41 < 0.0001
Genitalia 0.60 86.40 < 0.0001
PDS2 Pubic hair 0.54 66.22 < 0.0001
Genitalia 0.54 67.75 < 0.0001
PCS Pubic hair 0.40 51.82 < 0.0001
Genitalia 0.45 55.87 < 0.0001
Questions as levels 
of a PDS factor
Growth spurt 0.31
Body hair growth 0.53
Skin changes Pubic hair 0.31 97.00 < 0.0001
Voice changes 0.47
Facial hair growth 0.20
Growth spurt 0.34
Body hair growth 0.44
Skin changes Genitalia 0.23 86.02 < 0.0001
Voice changes 0.48
Facial hair growth 0.24
Females
Score
PDS1 Pubic hair 0.57 95.91 < 0.0001
Breasts 0.68 150.37 < 0.0001
PDS2 Pubic hair 0.31 33.11 < 0.0001
Breasts 0.39 42.58 < 0.0001
PCS Pubic hair 0.51 74.03 < 0.0001
Breasts 0.68 152.18 < 0.0001
Questions as levels 
of a PDS factor
Growth spurt 0.19
Body hair growth Pubic hair 0.46 4.36a < 0.006
Skin changes 0.21
Breast growth 0.06
Growth spurt 0.21
Body hair growth Genitalia 0.40 56.68 < 0.0001
Skin changes 0.20
Breast growth 0.16
Menarcheb Pubic hair 0.52 77.10 < 0.0001
Menarcheb Genitalia 0.65 133.60 < 0.0001
Multiple R2 are the proportion of variance explained in the PDS by the clinical ratings (R2 between 0.13 and 
0.25 = medium effect size; R2 > 0.26 = large effect size)23. PDS1 = mean score of answers to all five PDS 
questions; PDS2 = sum of score of answers to three PDS questions considered in the PCS (Pubertal Category 
Score); PCS = pubertal staging equivalent to the Tanner scale obtained from the PDS2 scoring system). See Box for 
scoring systems.
Score per question involved combining all continuous scores as different levels in a PDS factor; Degrees of 
freedom: males 1,57; females 1,72.
a interaction of clinical staging and the factor questions (degrees of freedom 3,216). 
b a separate model was run for menarche because it is answered with a dichotomous rating (yes or no).
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the GLM investigating the extent to which Tanner staging explained the variance 
in the three PDS scores reached high effects sizes (Table 3). Tanner ratings also 
significantly explained PDS ratings when answers to individual questions were levels 
of a PDS factor (Table 3).
The CFA for males showed excellent fit indices (Figure 1-A). A similar model was run for 
females, but it did not fit the data well (χ
(5)
 = 16.741, p = 0.0050; RMSEA = 0.167 and Cfit = 
0.015, CFI = 0.924 and TLI = 0.849), possibly because menarche is rated on a dichotomous 
scale and is less sensitive to the progressive changes during pubertal development. Because 
the PDS is multidimensional by reflecting both gonadal and adrenal changes assessed in 
the Tanner scale, we correlated residuals variance to menarche and growth of body hair, the 
two questions that best associated with gonadal and adrenal clinical ratings in the GLM, 
respectively. With this adjustment, the model for female showed excellent fit indices (Figure 
1-B). Scale reliability based on CFA results were 0.87 (males) and 0.71 (females). Pearson 
correlations of the latent PDS factor and Tanner staging were significant (p < 0.001): males 
r = 0.786 (pubic hair) and r = 0.726 (genital development); females r = 0.541 (pubic hair) and 
r = 0.738 (breast development).
Note: Fit indices for males: χ(5) = 3.393, p = 0.6397; RMSEA (root mean square error approximation) < 0.001 and 
Cfit (Close fit) = 0.714, CFI (Confirmatory Fit Index) = 1.000 and TLI (Tucker-Lewis index) = 1.013.
For females, the curved line represents an adjustment to the model, that is, a correlation of residual variances 
of menarche and growth of body hair (see Results section for details). Fit indices were: χ(4) = 4.804, p = 0.3080; 
RMSEA = 0.049 and Cfit = 0.413; CFI = 0.995 and TLI = 0.987.
Figure 1. Confirmatory factor analysis of the Pubertal Development Scale (PDS) scores for the model 
obtained from data from males (A) and females (B), including factor loadings on the pubertal development 
factor (represented as the oval) and their respectively standard errors in brackets.
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Pubertal 
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Growthspurt
Body hair growth
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Breast growth
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0.514 (0.10)
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0.675 (0.17)
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DISCUSSION
Overall, we found that the PDS is a self-assessment instrument that captures changes in 
pubertal development assessed by experienced clinicians. PDS raw scores (especially PDS1), 
and Tanner stages correlated well. They were higher than those found for females in the 
study by Brooks-Gunn et al.29 and similar to values from Schmitz et al.16 The PDS1 score was 
also the one best associated with clinical staging in GLM. Over 60% of the PDS variance for 
males and over 57% for females was explained by Tanner ratings (high effect sizes). The three 
PDS scores had mostly similar ICC for consistency (moderate to good). Good to excellent 
values were obtained comparing PDS2 score for females regarding pubic Tanner staging, 
and when comparing PCS scores and the genital Tanner scale in males. Hence, all scoring 
methods have merits. Nevertheless, the PDS1 includes more changes related to puberty and 
might be a better estimate of changes in youngsters’ bodies.
Regarding absolute agreement between self-rated PCS score and clinical staging, results 
were less positive. Absolute agreement ICC and weighted Kappa values were mostly low to 
good and slight to fair, respectively, with wide ranges of confidence intervals, suggesting 
that this scoring system does not map well onto Tanner stages, corroborating findings of 
Schmitz et al.16 and Shirtcliff et al.17 This is not surprising considering that the PDS measures 
pubertal events that are not considered by Tanner ratings. Also, clinical pubertal rating on 
the Tanner scale entails comparing adolescents among each other and with photographs 
that reflect pubertal stages regarding specific body characteristics, so it may not capture 
rapid changes in the body, which might be better noticed by the youngsters themselves when 
using the PDS17. Moreover, the PDS contemplates important changes related to puberty that 
the Tanner scale does not: growth in height3 and skin changes in both sexes14, menarche1 
in females and both facial hair13 and voice changes11 in males. Additionally, the PDS can be 
particularly useful in assessing self-perception of young people when body image and self-
esteem are of interest as well2.
Indeed, when scores of each PDS question were entered as separate levels in a PDS factor 
in GLM, we found that the variance explained in the PDS by Tanner ratings (R2) for each 
question were of medium to high effect sizes, with only one exception (R2 of Tanner pubic 
hair rating on the PDS breast growth question was 0.06, but that was still highly significant). 
Self-assessment of body hair growth was best related with pubic hair Tanner staging for 
both sexes (R2 = 53% males, 46% females), which makes sense as both are a consequence 
primarily of increases in adrenal hormones9,14. Growth spurt was related to pubic hair and 
breast/genital clinical staging in both sexes to a similar extent, confirming that it depends 
on both gonadal and adrenal stimulation3. In turn, for clinical staging of genital development 
in males, the most sensitive question was changes in voice (R2 = 51%), corroborating findings 
that this characteristic reflects gonadal effects11. Menarche explained 65% and 52% of breast 
and pubic hair clinical ratings respectively, showing that it relates more to gonadal than 
adrenal events, as it should1. Additionally, breast growth in the PDS was more associated 
with Tanner breast staging than pubic hair, which reflects the fact that breasts develop 
mostly because of gonadal stimulation12. Effect sizes in girls were smaller overall, probably 
because they were more sexually mature. Facial hair was the least sensitive question, 
unsurprisingly as it continues to grow well after Tanner stage 513. Similarly, skin changes 
continue until the end of adolescence14.
Regarding the CFA, we found that for males all questions loaded onto a single factor and fit 
the data well. Differently, an adjustment had to be made in the model with female data to 
reflect the multidimensional (gonadal and adrenal) nature of the scale1,8,11–14. For both sexes, 
the excellent factor solutions and correlations of the pubertal factor with clinical ratings 
show that working in the CFA environment is a good alternative when using the PDS. This 
CFA approach to analyze PDS data is a novel finding in the literature.
Internal consistency of data from male and female answers in the PDS computed based on 
CFA results showed the reliability of the scale. Importantly, in the female model we found 
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different magnitudes of factor loadings (ranging from 0.514 to 0.880). In such a situation, 
using Cronbach’s alpha is not recommend because the residual variances are correlated 
and the items do not load uniformly highly on the common PDS latent factor25,27. Although 
menarche is an unambiguous late event in gonadarche2, unlike the other PDS questions that 
have progressive ratings, menarche is a dichotomous variable and may impose limitations 
for Cronbach’s alpha calculation in our study and prior publications. Regardless of this, the 
reliabilities we found are similar to those of many other studies, which varied regarding 
higher alphas in males or females: this was so in the original version in English9,10 and the 
versions of the PDS translated into other languages such as Chinese19, Dutch30, Norwegian31, 
Spanish32, Finnish33, French34, and German35. In many cases, these alphas did not reach 
the lower acceptable boundary of 0.709,10,19,29, while both our reliability measures did so 
(0.71 for females; 0.87 for males).
In the study described here, physicians who evaluated the participants were experts in the 
field and showed equivalent ratings until the middle of the experiment, so we did not assess 
inter-rater variability. However, we cannot exclude that some variability among raters may 
have occurred thenceforth. This could have potentially biased results. Additionally, note 
that determining inter-rater reliability of clinical staging is not the norm in studies that 
compared PDS to clinical pubertal staging. Therefore, in this respect, our study is comparable 
to those in the literature.
In sum, good estimates of pubertal development may be obtained from the adapted version 
of the PDS into Portuguese and are acceptable if exact correspondence to Tanner stages 
is not necessary. Still, our results should be replicated in larger clinical and non-clinical 
populations, ideally with more individuals in each pubertal stage than those in our sample. 
Nonetheless, we believe that our results make an important contribution to the literature 
by providing a Portuguese version of the PDS, showing factor structure of the scale, which 
has not been done previously, and evidencing, with a variety of statistical approaches, 
that PDS scores relate well, albeit not exactly, to clinical Tanner staging, confirming data 
in the few international publications that compared these metrics. We conclude that the 
Portuguese version of the PDS is adequate for determining pubertal staging when clinical 
ratings are not possible. This scale can, therefore, contribute to the understanding of the 
body changes that occur in adolescence.
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